546 related articles for article (PubMed ID: 17221151)
1. Predictive factors for late normal tissue complications following radiotherapy for breast cancer.
Lilla C; Ambrosone CB; Kropp S; Helmbold I; Schmezer P; von Fournier D; Haase W; Sautter-Bihl ML; Wenz F; Chang-Claude J
Breast Cancer Res Treat; 2007 Nov; 106(1):143-50. PubMed ID: 17221151
[TBL] [Abstract][Full Text] [Related]
2. Effect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservation.
Johansen J; Overgaard J; Overgaard M
Acta Oncol; 2007; 46(4):525-33. PubMed ID: 17497320
[TBL] [Abstract][Full Text] [Related]
3. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
[TBL] [Abstract][Full Text] [Related]
4. Partial breast irradiation with interstitial 60CO brachytherapy results in frequent grade 3 or 4 toxicity. Evidence based on a 12-year follow-up of 70 patients.
Póti Z; Nemeskéri C; Fekésházy A; Sáfrány G; Bajzik G; Nagy ZP; Bidlek M; Sinkovics I; Udvarhelyi N; Liszkay G; Repa I; Galuska L; Trón L; Mayer A; Esik O
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1022-33. PubMed ID: 15001241
[TBL] [Abstract][Full Text] [Related]
5. Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation.
Hepel JT; Tokita M; MacAusland SG; Evans SB; Hiatt JR; Price LL; DiPetrillo T; Wazer DE
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1290-6. PubMed ID: 19395195
[TBL] [Abstract][Full Text] [Related]
6. TLD skin dose measurements and acute and late effects after lumpectomy and high-dose-rate brachytherapy only for early breast cancer.
Perera F; Chisela F; Stitt L; Engel J; Venkatesan V
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1283-90. PubMed ID: 16029783
[TBL] [Abstract][Full Text] [Related]
7. Long-term toxicity of an intraoperative radiotherapy boost using low energy X-rays during breast-conserving surgery.
Kraus-Tiefenbacher U; Bauer L; Scheda A; Fleckenstein K; Keller A; Herskind C; Steil V; Melchert F; Wenz F
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):377-81. PubMed ID: 16887294
[TBL] [Abstract][Full Text] [Related]
8. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer.
Hooning MJ; Botma A; Aleman BM; Baaijens MH; Bartelink H; Klijn JG; Taylor CW; van Leeuwen FE
J Natl Cancer Inst; 2007 Mar; 99(5):365-75. PubMed ID: 17341728
[TBL] [Abstract][Full Text] [Related]
9. Full-dose intraoperative radiotherapy with electrons in breast cancer. First report on late toxicity and cosmetic results from a single-institution experience.
Mussari S; Sabino Della Sala W; Busana L; Vanoni V; Eccher C; Zani B; Menegotti L; Tomio L
Strahlenther Onkol; 2006 Oct; 182(10):589-95. PubMed ID: 17013572
[TBL] [Abstract][Full Text] [Related]
10. Common variants of GSTP1, GSTA1, and TGFβ1 are associated with the risk of radiation-induced fibrosis in breast cancer patients.
Terrazzino S; La Mattina P; Gambaro G; Masini L; Franco P; Canonico PL; Genazzani AA; Krengli M
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):504-11. PubMed ID: 22079734
[TBL] [Abstract][Full Text] [Related]
11. Supraclavicular radiation for breast cancer does not increase the 10-year risk of stroke.
Woodward WA; Giordano SH; Duan Z; Hortobagyi GN; Buchholz TA
Cancer; 2006 Jun; 106(12):2556-62. PubMed ID: 16691617
[TBL] [Abstract][Full Text] [Related]
12. A cosmetic evaluation of breast cancer treatment: a randomized study of radiotherapy boost technique.
Vass S; Bairati I
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1274-82. PubMed ID: 16029782
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous integrated boost irradiation after breast-conserving surgery: physician-rated toxicity and cosmetic outcome at 30 months' follow-up.
Bantema-Joppe EJ; Schilstra C; de Bock GH; Dolsma WV; Busz DM; Langendijk JA; Maduro JH
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e471-7. PubMed ID: 22494592
[TBL] [Abstract][Full Text] [Related]
14. [Radiotherapy and delayed breast reconstruction with implant: examination of compatibility].
Fodor J; Gulyás G; Polgár C; Major T; Szabó E; Köves I; Pólus K; Németh G; Kásler M
Magy Onkol; 2002; 46(4):323-6. PubMed ID: 12563354
[TBL] [Abstract][Full Text] [Related]
15. Double-blind placebo-controlled randomised trial of vitamin E and pentoxifylline in patients with chronic arm lymphoedema and fibrosis after surgery and radiotherapy for breast cancer.
Gothard L; Cornes P; Earl J; Hall E; MacLaren J; Mortimer P; Peacock J; Peckitt C; Woods M; Yarnold J
Radiother Oncol; 2004 Nov; 73(2):133-9. PubMed ID: 15542159
[TBL] [Abstract][Full Text] [Related]
16. Early initiation of external beam radiotherapy (EBRT) may increase the risk of long-term toxicity in patients undergoing intraoperative radiotherapy (IORT) as a boost for breast cancer.
Wenz F; Welzel G; Keller A; Blank E; Vorodi F; Herskind C; Tomé O; Sütterlin M; Kraus-Tiefenbacher U
Breast; 2008 Dec; 17(6):617-22. PubMed ID: 18650091
[TBL] [Abstract][Full Text] [Related]
17. Predictors of lymphedema in patients with breast cancer undergoing axillary lymph node dissection in Hong Kong.
Mak SS; Yeo W; Lee YM; Mo KF; Tse KY; Tse SM; Ho FP; Kwan WH
Nurs Res; 2008; 57(6):416-25. PubMed ID: 19018216
[TBL] [Abstract][Full Text] [Related]
18. Effects of smoking and radiotherapy on lung carcinoma in breast carcinoma survivors.
Ford MB; Sigurdson AJ; Petrulis ES; Ng CS; Kemp B; Cooksley C; McNeese M; Selwyn BJ; Spitz MR; Bondy ML
Cancer; 2003 Oct; 98(7):1457-64. PubMed ID: 14508833
[TBL] [Abstract][Full Text] [Related]
19. Tumor location, interval between surgery and radiotherapy, and boost technique influence local control after breast-conserving surgery and radiation: retrospective analysis of monoinstitutional long-term results.
Knauerhase H; Strietzel M; Gerber B; Reimer T; Fietkau R
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1048-55. PubMed ID: 18359170
[TBL] [Abstract][Full Text] [Related]
20. Risk of radiation-induced subcutaneous fibrosis in relation to single nucleotide polymorphisms in TGFB1, SOD2, XRCC1, XRCC3, APEX and ATM--a study based on DNA from formalin fixed paraffin embedded tissue samples.
Andreassen CN; Alsner J; Overgaard M; Sørensen FB; Overgaard J
Int J Radiat Biol; 2006 Aug; 82(8):577-86. PubMed ID: 16966185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]